Status | Study |
Completed |
Study Name: Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia Condition: Community-acquired Bacterial Pneumonia Date: 2012-12-20 Interventions: Drug: Solithromycin Other Name |
Withdrawn |
Study Name: Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia Condition: Community-Acquired Bacterial Pneumonia (CABP) Date: 2012-08-14 Interventions: Drug: Ceftaroline fosamil IV ceftaroline fosamil 600 mg infused over 60 (± 10) minutes every 12 hou |
Completed |
Study Name: Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia Condition: Community Acquired Bacterial Pneumonia Date: 2012-05-16 Interventions: Drug: Efficacy of ceftaroline Determining the efficacy of ceftaroline compared to other cephalosporins |
Completed |
Study Name: Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit Condition: Pneumonia, Bacterial Date: 2012-03-07 Interventions: Other: 5 Days of Antibiotics T |
Completed |
Study Name: Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia Condition: Pneumonia, Bacterial Community-acquired Date: 2012-01-30 Interventions: Drug: Ceftaroline 600 mg Q12h |
Completed |
Study Name: A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia Condition: Community-Acquired Bacterial Pneumonia Lung Infection of Indivi Date: 2011-04-27 Interventions: Drug: Ceftaroline Two consecut |
Terminated |
Study Name: Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia Condition: Community-Acquired Bacterial Pneumonia (CABP) Date: 2010-09-07 Interventions: Drug: JNJ-32729463 150 mg intr |
Completed |
Study Name: The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP) Condition: Pneumonia, Bacterial Date: 2010-08-16 Interventions: Drug: ampicillin sodium/sulbactam sodium ampicillin sodium/sulbactam sodium is administered 12g/day (3 g |
Completed |
Study Name: Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia Condition: Community-Acquired Bacterial Pneumonia Date: 2010-07-22 Interventions: Drug: Levofloxacin |
Completed |
Study Name: Inhaled Amikacin Solution (BAY 41-6551) as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia Condition: Pneumonia, Bacterial Date: 2008-12-08 Interventions: Drug: Amikacin Inhalation Solution (BAY41-6551) |